Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-18T12:01:51.898Z Has data issue: false hasContentIssue false

Incidences of micro-deletion/duplication 22q11.2 detected by multiplex ligation-dependent probe amplification in patients with congenital cardiac disease who are scheduled for cardiac surgery

Published online by Cambridge University Press:  01 April 2009

Yali Hu
Affiliation:
Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Xiangyu Zhu
Affiliation:
Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Yuehua Yang
Affiliation:
Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu, China
Xuming Mo
Affiliation:
Department of Cardiothoracic Surgery, Nanjing Children’s Hospital, Nanjing, Jiangsu, China
Min Sheng
Affiliation:
Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu, China
Jincui Yao
Affiliation:
Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Dongjing Wang*
Affiliation:
Department of Cardiothoracic Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
*
Correspondence to: Dongjin Wang, Department of Cardiothoracic Surgery, Nanjing Drum Tower Hospital, 321 Zhongshan Boulevard, Nanjing, Jiangsu 210008, People’s Republic of China. Tel: 025-83105117; Fax: 025-83105117 or 025-83317016; E-mail: [email protected]

Abstract

Background

22q11.2 microdeletion is the most common microdeletion in the global population. Congenital cardiac disease is the most frequently observed feature of this syndrome. The prognosis of patients with 22q11.2 copy number aberrations varies from those without 22q11.2 deletion or duplication.

Methods

We enrolled 241 patients from Nanjing Drum Tower Hospital and Nanjing Sick Children’s Hospital, 227 being scheduled for cardiac surgery, and 14 cases being fetuses aged from 24 to 36 gestational weeks. We performed karyotypic analysis and multiplex ligation-dependent probe amplification in all cases.

Results

Karyotypic analysis demonstrated 3 cases with trisomy 21, and 1 case with mosaic trisomy 8 [47,XY,+8/46,XY(1:2)]. Multiplex ligation-dependent probe amplification analysis revealed 10 cases (4.15%) with changes in the number of copies within the region of 22q11.2, of which 7 cases were hemizygous interstitial microdeletion from CLTCL1 to LZTR1, 1 case with deletion of the region from CLTCL1 to PCQAP, and 2 cases with 22q11.2 duplication, one of which spanned from ZNF74 to LZTR1, and simultaneously showed trisomy 21 by karyotyping analysis, and the other spanned from HIC2 to TOP3B. The phenotypes of the cardiac lesions included 3 cases of ventricular septal defect, 3 of tetralogy of Fallot, 2 of combined ventricular and atrial septal defects, and 2 with pulmonary arterial stenosis.

Conclusions

Patients with congenitally malformed hearts who are scheduled for cardiac surgery, as well as fetuses with congenital cardiac disease, should routinely undergo karyotypic analysis and examination for 22q11.2 aberrations. Multiplex ligation-dependent probe amplification has been proven to be a cost-effective diagnostic technique for 22q11 deletion syndrome.

Type
Original Article
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Scambler, PJ. The 22q11 deletion syndromes. Hum Mol Genet 2000; 9: 24212426.CrossRefGoogle ScholarPubMed
2.Hay, BN. Deletion 22q11: Spectrum of associated disorders. Semin Pediatr Neurol 2007; 14: 136139.CrossRefGoogle ScholarPubMed
3.McDonald-Mcginn, DM, Kirschner, R, Goldmuntz, E, et al. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 1999; 10: 1124.Google ScholarPubMed
4.Kyburz, A, Bauersfild, U, Schinzel, A, et al. The fate of children with microdeletion 22q11.2 syndrome and congenital heart defect: clinical course and cardiac outcome. Pediatr Cardiol 2008; 29: 7683.CrossRefGoogle ScholarPubMed
5.Weismann, CG, Gelb, BD. The genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol 2007; 22: 200206.CrossRefGoogle ScholarPubMed
6.Jalali, GR, Vorstman, JAS, Errami, A, et al. Detailed analysis of 22q11.2 with a high density MLPA probe set. Hum Mutat 2008; 29: 433440.CrossRefGoogle ScholarPubMed
7.Fernández, L, Lapunzina, P, Arjona, D, et al. Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin Genet 2005; 68: 373378.CrossRefGoogle ScholarPubMed
8.Yi, L, Xu, ZF, Mo, XM, et al. New tetranucleotide STRP markers for detecting the 22q11.2 deletion. Mol Cell Prob 2006; 20: 359365.CrossRefGoogle ScholarPubMed
9.Hu, YL, Zheng, MM, Xu, ZF, Wang, XR, Cui, HM. Quantitative real-time PCR technique for rapid prenatal diagnosis of Down syndrome. Prenat Diagn 2004; 24: 704707.CrossRefGoogle ScholarPubMed
10.Janssen, B, Hartmann, C, Scholz, V, Jauch, A, Zschocke, J. MLPA analysis for the detection of deletions, duplications, and complex rearrangements in the dystrophin geen: potential and pitfalls. Neruogenenetics 2005; 6: 2935.CrossRefGoogle Scholar
11.Stachon, AC, Baskin, B, Smith, AC, et al. Molecular diagnosis of 22q11.2 deletion and duplication by multiplex ligation dependent probe amplification. Am J Med Genet 2007; 143A: 29242930.CrossRefGoogle ScholarPubMed
12.Zhang, XQ, Xu, ZF, Yi, L, et al. Rapid detection of 22q11 micro-deletion with quantitative real-time polymerase chain reaction. J Appl Clin Pediatr 2006; 21: 14091410.Google Scholar
13.Botto, LD, May, K, Fernhoff, PM, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112: 101107.CrossRefGoogle ScholarPubMed